STEM CELL BANKING AND THERAPY IN INDIA
Stem Cell Banking and Research is our forte. With the technological know-how and expertise of banking from 10 different sources, ReeLabs is India's first and only bank with the capabilities to offer Amniotic Sac, Amniotic Fluid and Placental Stem Cell Banking facility along with Cord Blood and Cord Tissue. Our commitment to stem cells has successfully helped over 1,00,000 people from all walks of life. Our tie-ups with over 300 hospitals, medical centres and specialty clinics across India help us to be there for you whenever and wherever you need us. Using state of the art technology, we ensure the highest count and viability of cells, so that they can be effectively used for treatment, when required.
You can get in touch with us by filling out the contact form, or by giving us a call on our Toll Free no: 1800-222-454 (Mon-Fri, 10am-6pm).
OUR SERVICES

COVID-19
INDIA'S FIRST AND ONLY STEM CELL TRIAL AGAINST COVID-19
ReeLabs Pvt. Ltd. has received permission from the Central Licensing Authority to conduct the FIRST and ONLY clinical trial in India using Mesenchymal stem cells derived from Placenta and Umbilical Cord Tissue in the fight against COVID-19.

REELABS IN NUMBERS
10
PATENTS
7
CLINICAL TRIALS
15
PROPRIETARY INVENTIONS
300+
INTERNATIONAL PUBLICATIONS
RECOGNITION
MOST INNOVATIVE STEM CELL RESEARCH FACILITY
ReeLabs is a proud recipient of the Global Healthcare and Pharmaceutical Award, 2021 in the category of the 'Most Innovative Stem Cell Research Facility'!
ReeLabs is the first Asian Enterprise to have won this prestigious award.
